Graft-versus-host disease in B− and B+ severe combined immunodeficient patients with maternal T cells
| . | Patients . | GVHD . | ||
|---|---|---|---|---|
| None . | Mild . | Severe . | ||
| B− SCID | 16 | 8 | — | 8 |
| RAG 1/2 mutation | ||||
| Yes | 5 | 3 | — | 2 |
| No | 8 | 3 | — | 5 |
| Not tested | 3 | 2 | — | 1 |
| B+SCID | 26 | 17 | 8 | 1 |
| Yc mutation | ||||
| Yes | 10 | 7 | 3 | — |
| No | 9 | 6 | 2 | 1 |
| Not tested | 7 | 4 | 3 | — |
| . | Patients . | GVHD . | ||
|---|---|---|---|---|
| None . | Mild . | Severe . | ||
| B− SCID | 16 | 8 | — | 8 |
| RAG 1/2 mutation | ||||
| Yes | 5 | 3 | — | 2 |
| No | 8 | 3 | — | 5 |
| Not tested | 3 | 2 | — | 1 |
| B+SCID | 26 | 17 | 8 | 1 |
| Yc mutation | ||||
| Yes | 10 | 7 | 3 | — |
| No | 9 | 6 | 2 | 1 |
| Not tested | 7 | 4 | 3 | — |
Data are given as number of patients.
GVHD indicates graft-versus-host disease; SCID, severe combined immunodeficiency.